Osphos is an injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome in horses 4 years and older. Osphos inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts.
This pharmacy is offered as a service to Oakencroft Equine's clients. If you are not a client of Oakencroft Equine your order will be cancelled and refunded. To become a client click here.
Choosing a selection results in a full page refresh.
